- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Platinum-based Anticancer APIs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Platinum-based Anticancer APIs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Platinum-based Anticancer APIs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Platinum-based Anticancer APIs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Market segment by Application can be divided into
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
The key market players for global Platinum-based Anticancer APIs market are listed below:
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Platinum-based Anticancer APIs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Platinum-based Anticancer APIs, with price, sales, revenue and global market share of Platinum-based Anticancer APIs in 2018 and 2019.
Chapter 3, the Platinum-based Anticancer APIs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum-based Anticancer APIs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Platinum-based Anticancer APIs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Platinum-based Anticancer APIs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Platinum-based Anticancer APIs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Platinum-based Anticancer APIs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Platinum-based Anticancer APIs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Platinum-based Anticancer APIs Market Size & Forecast
1.4.1 Global Platinum-based Anticancer APIs Sales in Value (2016-2026))
1.4.2 Global Platinum-based Anticancer APIs Sales in Volume (2016-2026)
1.4.3 Global Platinum-based Anticancer APIs Price by Type (2016-2026) & (US$/Ton)
1.5 Global Platinum-based Anticancer APIs Production Capacity Analysis
1.5.1 Global Platinum-based Anticancer APIs Total Production Capacity (2016-2026)
1.5.2 Global Platinum-based Anticancer APIs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Platinum-based Anticancer APIs Market Drivers
1.6.2 Platinum-based Anticancer APIs Market Restraints
1.6.3 Platinum-based Anticancer APIs Trends Analysis
2 Manufacturers Profiles
2.1 Jiangsu Hengrui Medicine
2.1.1 Jiangsu Hengrui Medicine Details
2.1.2 Jiangsu Hengrui Medicine Major Business
2.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product and Services
2.1.4 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Nanjing Pharmaceutical Factory
2.2.1 Nanjing Pharmaceutical Factory Details
2.2.2 Nanjing Pharmaceutical Factory Major Business
2.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product and Services
2.2.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Qilu Pharmaceutical
2.3.1 Qilu Pharmaceutical Details
2.3.2 Qilu Pharmaceutical Major Business
2.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.3.4 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Neptunus
2.4.1 Neptunus Details
2.4.2 Neptunus Major Business
2.4.3 Neptunus Platinum-based Anticancer APIs Product and Services
2.4.4 Neptunus Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hisun
2.5.1 Hisun Details
2.5.2 Hisun Major Business
2.5.3 Hisun Platinum-based Anticancer APIs Product and Services
2.5.4 Hisun Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Jiangsu HaiCi biological pharmaceutical
2.6.1 Jiangsu HaiCi biological pharmaceutical Details
2.6.2 Jiangsu HaiCi biological pharmaceutical Major Business
2.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product and Services
2.6.4 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Kunming Guiyan Pharmaceutical
2.7.1 Kunming Guiyan Pharmaceutical Details
2.7.2 Kunming Guiyan Pharmaceutical Major Business
2.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.7.4 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Lingnan Pharmacy
2.8.1 Lingnan Pharmacy Details
2.8.2 Lingnan Pharmacy Major Business
2.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Product and Services
2.8.4 Lingnan Pharmacy Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Jinzhou Jiutai Pharmaceutical
2.9.1 Jinzhou Jiutai Pharmaceutical Details
2.9.2 Jinzhou Jiutai Pharmaceutical Major Business
2.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.9.4 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Nanjing Hairun Pharmaceutical
2.10.1 Nanjing Hairun Pharmaceutical Details
2.10.2 Nanjing Hairun Pharmaceutical Major Business
2.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.10.4 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Simcere
2.11.1 Simcere Details
2.11.2 Simcere Major Business
2.11.3 Simcere Platinum-based Anticancer APIs Product and Services
2.11.4 Simcere Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Platinum-based Anticancer APIs Product and Services
2.12.4 Teva Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Platinum-based Anticancer APIs Product and Services
2.13.4 Cipla Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Heraeus
2.14.1 Heraeus Details
2.14.2 Heraeus Major Business
2.14.3 Heraeus Platinum-based Anticancer APIs Product and Services
2.14.4 Heraeus Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Hospira(Pfizer)
2.15.1 Hospira(Pfizer) Details
2.15.2 Hospira(Pfizer) Major Business
2.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Product and Services
2.15.4 Hospira(Pfizer) Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Taj Pharmaceuticals
2.16.1 Taj Pharmaceuticals Details
2.16.2 Taj Pharmaceuticals Major Business
2.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Product and Services
2.16.4 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Umicore Precious Metals Chemistry
2.17.1 Umicore Precious Metals Chemistry Details
2.17.2 Umicore Precious Metals Chemistry Major Business
2.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product and Services
2.17.4 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Platinum-based Anticancer APIs Sales by Manufacturer
3.1 Global Platinum-based Anticancer APIs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Platinum-based Anticancer APIs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Platinum-based Anticancer APIs
3.4 Market Concentration Rate
3.4.1 Top 3 Platinum-based Anticancer APIs Manufacturer Market Share
3.4.2 Top 6 Platinum-based Anticancer APIs Manufacturer Market Share
3.5 Global Platinum-based Anticancer APIs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Platinum-based Anticancer APIs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Platinum-based Anticancer APIs Market Size by Region
4.1.1 Global Platinum-based Anticancer APIs Sales in Volume by Region (2016-2026)
4.1.2 Global Platinum-based Anticancer APIs Revenue by Region (2016-2026)
4.2 North America Platinum-based Anticancer APIs Revenue (2016-2026)
4.3 Europe Platinum-based Anticancer APIs Revenue (2016-2026)
4.4 Asia-Pacific Platinum-based Anticancer APIs Revenue (2016-2026)
4.5 South America Platinum-based Anticancer APIs Revenue (2016-2026)
4.6 Middle East and Africa Platinum-based Anticancer APIs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Platinum-based Anticancer APIs Sales in Volume by Type (2016-2026)
5.2 Global Platinum-based Anticancer APIs Revenue by Type (2016-2026)
5.3 Global Platinum-based Anticancer APIs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Platinum-based Anticancer APIs Sales in Volume by Application (2016-2026)
6.2 Global Platinum-based Anticancer APIs Revenue by Application (2016-2026)
6.3 Global Platinum-based Anticancer APIs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Platinum-based Anticancer APIs Sales by Type (2016-2026)
7.2 North America Platinum-based Anticancer APIs Sales by Application (2016-2026)
7.3 North America Platinum-based Anticancer APIs Market Size by Country
7.3.1 North America Platinum-based Anticancer APIs Sales in Volume by Country (2016-2026)
7.3.2 North America Platinum-based Anticancer APIs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Platinum-based Anticancer APIs Sales by Type (2016-2026)
8.2 Europe Platinum-based Anticancer APIs Sales by Application (2016-2026)
8.3 Europe Platinum-based Anticancer APIs Market Size by Country
8.3.1 Europe Platinum-based Anticancer APIs Sales in Volume by Country (2016-2026)
8.3.2 Europe Platinum-based Anticancer APIs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Platinum-based Anticancer APIs Sales by Type (2016-2026)
9.2 Asia-Pacific Platinum-based Anticancer APIs Sales by Application (2016-2026)
9.3 Asia-Pacific Platinum-based Anticancer APIs Market Size by Region
9.3.1 Asia-Pacific Platinum-based Anticancer APIs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Platinum-based Anticancer APIs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Platinum-based Anticancer APIs Sales by Type (2016-2026)
10.2 South America Platinum-based Anticancer APIs Sales by Application (2016-2026)
10.3 South America Platinum-based Anticancer APIs Market Size by Country
10.3.1 South America Platinum-based Anticancer APIs Sales in Volume by Country (2016-2026)
10.3.2 South America Platinum-based Anticancer APIs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Platinum-based Anticancer APIs Sales by Type (2016-2026)
11.2 Middle East & Africa Platinum-based Anticancer APIs Sales by Application (2016-2026)
11.3 Middle East & Africa Platinum-based Anticancer APIs Market Size by Country
11.3.1 Middle East & Africa Platinum-based Anticancer APIs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Platinum-based Anticancer APIs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Platinum-based Anticancer APIs Typical Distributors
12.3 Platinum-based Anticancer APIs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Platinum-based Anticancer APIs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Platinum-based Anticancer APIs Revenue by Application, (USD Million), 2021-2026
Table 3. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 4. Jiangsu Hengrui Medicine Major Business
Table 5. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product and Services
Table 6. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Nanjing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 8. Nanjing Pharmaceutical Factory Major Business
Table 9. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product and Services
Table 10. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Qilu Pharmaceutical Major Business
Table 13. Qilu Pharmaceutical Platinum-based Anticancer APIs Product and Services
Table 14. Qilu Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Neptunus Basic Information, Manufacturing Base and Competitors
Table 16. Neptunus Major Business
Table 17. Neptunus Platinum-based Anticancer APIs Product and Services
Table 18. Neptunus Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hisun Basic Information, Manufacturing Base and Competitors
Table 20. Hisun Major Business
Table 21. Hisun Platinum-based Anticancer APIs Product and Services
Table 22. Hisun Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Jiangsu HaiCi biological pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu HaiCi biological pharmaceutical Major Business
Table 25. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product and Services
Table 26. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Kunming Guiyan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Kunming Guiyan Pharmaceutical Major Business
Table 29. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product and Services
Table 30. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lingnan Pharmacy Basic Information, Manufacturing Base and Competitors
Table 32. Lingnan Pharmacy Major Business
Table 33. Lingnan Pharmacy Platinum-based Anticancer APIs Product and Services
Table 34. Lingnan Pharmacy Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Jinzhou Jiutai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Jinzhou Jiutai Pharmaceutical Major Business
Table 37. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product and Services
Table 38. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Nanjing Hairun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Nanjing Hairun Pharmaceutical Major Business
Table 41. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product and Services
Table 42. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Simcere Basic Information, Manufacturing Base and Competitors
Table 44. Simcere Major Business
Table 45. Simcere Platinum-based Anticancer APIs Product and Services
Table 46. Simcere Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Teva Basic Information, Manufacturing Base and Competitors
Table 48. Teva Major Business
Table 49. Teva Platinum-based Anticancer APIs Product and Services
Table 50. Teva Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Cipla Basic Information, Manufacturing Base and Competitors
Table 52. Cipla Major Business
Table 53. Cipla Platinum-based Anticancer APIs Product and Services
Table 54. Cipla Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Heraeus Basic Information, Manufacturing Base and Competitors
Table 56. Heraeus Major Business
Table 57. Heraeus Platinum-based Anticancer APIs Product and Services
Table 58. Heraeus Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Hospira(Pfizer) Basic Information, Manufacturing Base and Competitors
Table 60. Hospira(Pfizer) Major Business
Table 61. Hospira(Pfizer) Platinum-based Anticancer APIs Product and Services
Table 62. Hospira(Pfizer) Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Taj Pharmaceuticals Major Business
Table 65. Taj Pharmaceuticals Platinum-based Anticancer APIs Product and Services
Table 66. Taj Pharmaceuticals Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Umicore Precious Metals Chemistry Basic Information, Manufacturing Base and Competitors
Table 68. Umicore Precious Metals Chemistry Major Business
Table 69. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product and Services
Table 70. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Platinum-based Anticancer APIs Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 72. Global Platinum-based Anticancer APIs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Platinum-based Anticancer APIs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Platinum-based Anticancer APIs Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 75. Head Office and Platinum-based Anticancer APIs Production Site of Key Manufacturer
Table 76. Platinum-based Anticancer APIs New Entrant and Capacity Expansion Plans
Table 77. Platinum-based Anticancer APIs Mergers & Acquisitions in the Past Five Years
Table 78. Global Platinum-based Anticancer APIs Sales by Region (2016-2021e) & (Kiloton)
Table 79. Global Platinum-based Anticancer APIs Sales by Region (2021-2026) & (Kiloton)
Table 80. Global Platinum-based Anticancer APIs Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global Platinum-based Anticancer APIs Revenue by Region (2021-2026) & (USD Million)
Table 82. Global Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 83. Global Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 84. Global Platinum-based Anticancer APIs Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global Platinum-based Anticancer APIs Revenue by Type (2021-2026) & (USD Million)
Table 86. Global Platinum-based Anticancer APIs Price by Type (2016-2021e) & (US$/Ton)
Table 87. Global Platinum-based Anticancer APIs Price by Type (2021-2026) & (US$/Ton)
Table 88. Global Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 89. Global Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 90. Global Platinum-based Anticancer APIs Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global Platinum-based Anticancer APIs Revenue by Application (2021-2026) & (USD Million)
Table 92. Global Platinum-based Anticancer APIs Price by Application (2016-2021e) & (US$/Ton)
Table 93. Global Platinum-based Anticancer APIs Price by Application (2021-2026) & (US$/Ton)
Table 94. North America Platinum-based Anticancer APIs Sales by Country (2016-2021e) & (Kiloton)
Table 95. North America Platinum-based Anticancer APIs Sales by Country (2021-2026) & (Kiloton)
Table 96. North America Platinum-based Anticancer APIs Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America Platinum-based Anticancer APIs Revenue by Country (2021-2026) & (USD Million)
Table 98. North America Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 99. North America Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 100. North America Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 101. North America Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 102. Europe Platinum-based Anticancer APIs Sales by Country (2016-2021e) & (Kiloton)
Table 103. Europe Platinum-based Anticancer APIs Sales by Country (2021-2026) & (Kiloton)
Table 104. Europe Platinum-based Anticancer APIs Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe Platinum-based Anticancer APIs Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 107. Europe Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 108. Europe Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 109. Europe Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 110. Asia-Pacific Platinum-based Anticancer APIs Sales by Region (2016-2021e) & (Kiloton)
Table 111. Asia-Pacific Platinum-based Anticancer APIs Sales by Region (2021-2026) & (Kiloton)
Table 112. Asia-Pacific Platinum-based Anticancer APIs Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific Platinum-based Anticancer APIs Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 115. Asia-Pacific Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 116. Asia-Pacific Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 117. Asia-Pacific Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 118. South America Platinum-based Anticancer APIs Sales by Country (2016-2021e) & (Kiloton)
Table 119. South America Platinum-based Anticancer APIs Sales by Country (2021-2026) & (Kiloton)
Table 120. South America Platinum-based Anticancer APIs Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America Platinum-based Anticancer APIs Revenue by Country (2021-2026) & (USD Million)
Table 122. South America Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 123. South America Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 124. South America Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 125. South America Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 126. Middle East & Africa Platinum-based Anticancer APIs Sales by Country (2016-2021e) & (Kiloton)
Table 127. Middle East & Africa Platinum-based Anticancer APIs Sales by Country (2021-2026) & (Kiloton)
Table 128. Middle East & Africa Platinum-based Anticancer APIs Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa Platinum-based Anticancer APIs Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa Platinum-based Anticancer APIs Sales by Type (2016-2021e) & (Kiloton)
Table 131. Middle East & Africa Platinum-based Anticancer APIs Sales by Type (2021-2026) & (Kiloton)
Table 132. Middle East & Africa Platinum-based Anticancer APIs Sales by Application (2016-2021e) & (Kiloton)
Table 133. Middle East & Africa Platinum-based Anticancer APIs Sales by Application (2021-2026) & (Kiloton)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. Platinum-based Anticancer APIs Typical Distributors
Table 137. Platinum-based Anticancer APIs Typical Customers
List of Figures
Figure 1. Platinum-based Anticancer APIs Picture
Figure 2. Global Platinum-based Anticancer APIs Sales Market Share by Type in 2020
Figure 3. Cisplatin
Figure 4. Carboplatin
Figure 5. Oxaliplatin
Figure 6. Nedaplatin
Figure 7. Others
Figure 8. Global Platinum-based Anticancer APIs Sales Market Share by Application in 2020
Figure 9. Testicular Cancer
Figure 10. Osteosarcoma
Figure 11. Breast Cancer
Figure 12. Esophageal Cancer
Figure 13. NSCLC
Figure 14. Other
Figure 15. Global Platinum-based Anticancer APIs Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 16. Global Platinum-based Anticancer APIs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Platinum-based Anticancer APIs Sales (2016-2026) & (Kiloton)
Figure 18. Global Platinum-based Anticancer APIs Price by Type (2016-2026) & (US$/Ton)
Figure 19. Global Platinum-based Anticancer APIs Production Capacity (2016-2026) & (Kiloton)
Figure 20. Global Platinum-based Anticancer APIs Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Platinum-based Anticancer APIs Market Drivers
Figure 22. Platinum-based Anticancer APIs Market Restraints
Figure 23. Platinum-based Anticancer APIs Market Trends
Figure 24. Global Platinum-based Anticancer APIs Sales Market Share by Manufacturer in 2020
Figure 25. Global Platinum-based Anticancer APIs Revenue Market Share by Manufacturer in 2020
Figure 26. Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Platinum-based Anticancer APIs Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Platinum-based Anticancer APIs Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Platinum-based Anticancer APIs Sales Market Share by Region (2016-2026)
Figure 30. Global Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2026)
Figure 31. North America Platinum-based Anticancer APIs Revenue (2016-2026) & (USD Million)
Figure 32. Europe Platinum-based Anticancer APIs Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Platinum-based Anticancer APIs Revenue (2016-2026) & (USD Million)
Figure 34. South America Platinum-based Anticancer APIs Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Platinum-based Anticancer APIs Revenue (2016-2026) & (USD Million)
Figure 36. Global Platinum-based Anticancer APIs Sales Market Share by Type (2016-2026)
Figure 37. Global Platinum-based Anticancer APIs Revenue Market Share by Type (2016-2026)
Figure 38. Global Platinum-based Anticancer APIs Price by Type (2016-2026) & (US$/Ton)
Figure 39. Global Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 40. Global Platinum-based Anticancer APIs Revenue Market Share by Application (2016-2026)
Figure 41. Global Platinum-based Anticancer APIs Price by Application (2016-2026) & (US$/Ton)
Figure 42. North America Platinum-based Anticancer APIs Sales Market Share by Type (2016-2026)
Figure 43. North America Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 44. North America Platinum-based Anticancer APIs Sales Market Share by Country (2016-2026)
Figure 45. North America Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2026)
Figure 46. United States Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Platinum-based Anticancer APIs Sales Market Share by Type (2016-2026)
Figure 50. Europe Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 51. Europe Platinum-based Anticancer APIs Sales Market Share by Country (2016-2026)
Figure 52. Europe Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Platinum-based Anticancer APIs Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Platinum-based Anticancer APIs Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Platinum-based Anticancer APIs Revenue Market Share by Region (2016-2026)
Figure 62. China Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Platinum-based Anticancer APIs Sales Market Share by Type (2016-2026)
Figure 69. South America Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 70. South America Platinum-based Anticancer APIs Sales Market Share by Country (2016-2026)
Figure 71. South America Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Platinum-based Anticancer APIs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Platinum-based Anticancer APIs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Platinum-based Anticancer APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
